A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).
Clinical trial NCT05919680 · RECRUITING
Trial details
- NCT number
- NCT05919680
- Sponsor
- NorthSea Therapeutics B.V.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-15
- Primary completion
- 2025-06-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.